A genetically encoded bifunctional enzyme mitigates redox imbalance and lipotoxicity
- 16 February 2026
- journal article
- research article
- Published by Springer Nature in Nature Metabolism
- Vol. 8 (2) , 350-370
Abstract
Dihydroxyacetone phosphate (DHAP), glycerol-3-phosphate (Gro3P) and reduced/oxidized nicotinamide adenine dinucleotide (NADH/NAD⁺) are key metabolites of the Gro3P shuttle, which transfers reducing equivalents between the cytosol and mitochondria. Targeted activation of Gro3P biosynthesis has recently emerged as a promising strategy to alleviate reductive stress. However, because Gro3P constitutes the backbone of triglycerides, its accumulation can promote extensive lipogenesis. Here we show that a genetically encoded tool based on a di-domain glycerol-3-phosphate dehydrogenase from the alga Chlamydomonas reinhardtii (CrGPDH) effectively operates both the alternative Gro3P shunt, which regenerates NAD⁺ while converting DHAP to Gro3P, and the glycerol shunt, which converts Gro3P to glycerol and inorganic phosphate, across transformed and primary mammalian cell cultures as well as mouse liver. CrGPDH expression supported proliferation of cancer cells under respiratory chain inhibition or hypoxia, as well as patient-derived fibroblasts with mitochondrial dysfunction. Moreover, CrGPDH decreased triglyceride levels in kidney cancer cell lines and reversed ethanol-induced triglyceride accumulation in mouse liver. Thus, CrGPDH represents a promising xenotopic tool to alleviate redox imbalance and associated impaired lipogenesis in conditions ranging from primary mitochondrial diseases to steatosis.Keywords
Funding Information
- National Institute of General Medical Sciences (R35GM142495)
- National Cancer Institute (R03CA286706)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK134675)
This publication has 85 references indexed in Scilit:
- Glycolysis model shows that allostery maintains high ATP and limits accumulation of intermediatesBiophysical Journal, 2025
- SURF1 Deficiency: Expanding on Disease Phenotype and Assessing Disease Burden by Describing Clinical and Biochemical PhenotypeAmerican Journal of Medical Genetics Part A, 2024
- ACSF2 and lysine lactylation contribute to renal tubule injury in diabetesDiabetologia, 2024
- Analysis of Melanoma Cell Glutamine Metabolism by Stable Isotope Tracing and Gas Chromatography-Mass Spectrometry2021
- RNAi Transfection Results in Lipidome ChangesProteomics, 2019
- The Skyline ecosystem: Informatics for quantitative mass spectrometry proteomicsMass Spectrometry Reviews, 2017
- Absolute Quantification of Matrix Metabolites Reveals the Dynamics of Mitochondrial MetabolismCell, 2016
- Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver diseaseJournal of Gastroenterology, 2013
- Cloning and characterization of two novel chloroplastic glycerol-3-phosphate dehydrogenases from Dunaliella viridisPlant Molecular Biology, 2009
- Differential features of patients with mutations in two COX assembly genes,SURF-1 andSCO2Annals of Neurology, 2000